Benefit From the Power of AI With Our High-Quality Picks
Invest with confidence knowing that StockStory’s team of analysts combine their expertise with our proprietary AI-driven algorithms to find edges in the market.
StockStory
+175.5%Total 5Y Return
S&P 500
+93.6%Total 5Y Return
Sep 2019
Sep 2024
Strong Momentum
These companies display elite fundamentals, first and foremost, which will help them beat the market over a multi-year period. However, something good is also going on with these stocks here and now. They are outperforming the market over the near term, signaling that there’s been a positive catalyst such as constructive newsflow or a market that is better appreciating how special these businesses are.
UnitedHealth (UNH)
With over 100 million people served across its various businesses and a workforce of more than 400,000, UnitedHealth Group (NYSE:UNH) operates a health insurance business and Optum, a healthcare services division that provides everything from pharmacy benefits to primary care.
Why We Like It:
UnitedHealth’s scale gives it meaningful leverage when negotiating reimbursement rates and its market-beating ROIC illustrates its ability to invest in highly profitable ventures. This is a prime example of a "high-quality" business.
Elevance Health (ELV)
Formerly known as Anthem until its 2022 rebranding, Elevance Health (NYSE:ELV) is one of America's largest health insurers, serving approximately 47 million medical members through its network-based managed care plans.
Why We Like It:
Elevance Health’s scale gives it meaningful leverage when negotiating reimbursement rates and its remarkable ROIC underscores its knack for targeting and investing in highly profitable growth initiatives. This is one of our top healthcare stocks.
Cencora (COR)
Formerly known as AmerisourceBergen until its 2023 rebranding, Cencora (NYSE:COR) is a global pharmaceutical distribution company that connects manufacturers with healthcare providers while offering logistics, data analytics, and consulting services.
Why We Like It:
Cencora’s scale gives it meaningful leverage when negotiating reimbursement rates and its stellar 64.3% ROIC illustrates management’s exceptional investing abilities. No coincidence the stock is up 228% over the last five years.
Palantir (PLTR)
Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE:PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.
Why We Like It:
Palantir’s best-in-class 43.6% free cash flow margins give it the resources it needs to beat the competition. Additionally, its excellent projected revenue growth suggests it’s poised to win significant market share. This is a splendid business you don’t see often.
Celsius (CELH)
With its proprietary MetaPlus formula as the basis for key products, Celsius (NASDAQ:CELH) offers energy drinks that feature natural ingredients to help in fitness and weight management.
Why We Like It:
Celsius is in a league of its own. Its rare mix of high revenue growth, exceptional profitability, and promising prospects makes it a staple in our portfolio. No coincidence the stock is up 2,268% over the last five years.